FrancophonIA/ELRC3.0 huggingface dataset:
English: Following administration of SIMBRINZA, small decreases in blood pressure were observed in some patients.
Croatian: Nakon primjene SIMBRINZE u nekih bolesnika zabilježena su manja sniženja krvnog tlaka.
English: Uncommon: red blood cells decreased
Croatian: Nepoznato: rinitis Poremećaji krvi i limfnog sustava Manje često: smanjen broj crvenih krvnih stanica
English: Uncommon: back pain
Croatian: Manje često: bol u leđima
English: 1, photopsia
Croatian: 1, fotofobija
English: SIMBRINZA has not been studied in patients with hepatic impairment; caution should be used in treating such patients (see section 4.2).
Croatian: SIMBRINZA nije ispitana kod bolesnika s oštećenom jetrenom funkcijom, stoga je pri liječenju takvih bolesnika potreban oprez (vidjeti dio 4.2).
English: Brimonidine
Croatian: Brimonidin
English: 3, ocular hyperaemia
Croatian: 3, hiperemija oka
English: 1, visual acuity reduced
Croatian: 1, smanjena oštrina vida
English: There is very limited information regarding accidental ingestion with the brimonidine component of SIMBRINZA in adults.
Croatian: Podaci o nehotičnom gutanju sastojka SIMBRINZE brimonidina u odraslih osoba vrlo su ograničeni.
English: Patients with severe renal impairment (see section 4.4).
Croatian: Bolesnici sa teško oštećenom bubrežnom funkcijom (vidjeti dio 4.4).
English: 1, urticaria
Croatian: 1, upala
English: Clinical data on the use of SIMBRINZA adjunctive to travoprost-timolol maleate fixed dose combination eye drops, solution also showed superior IOP-lowering efficacy of SIMBRINZA + travoprost-timolol maleate eye drops compared with the travoprost-timolol maleate alone.
Croatian: Klinički podaci o dodatnoj primjeni SIMBRINZE uz kapi za oči, otopina, koje sadrže kombinaciju fiksnih doza travoprosta i timololmaleata također su pokazali superiornu učinkovitost SIMBRINZE + travoprost-timololmaleat kapi za oči na sniženje IOT-a u usporedbi sa samim travoprost-timololmaleatom.
English: What SIMBRINZA contains - The active substances are brinzolamide and brimonidine tartrate.
Croatian: Što SIMBRINZA sadrži - Djelatne tvari su brinzolamid i brimonidintartarat.
English: The use of SIMBRINZA is not recommended during breast-feeding.
Croatian: Primjena SIMBRINZE ne preporučuje se tijekom dojenja.
English: Each mL of suspension contains 0.03 mg of benzalkonium chloride.
Croatian: Pomoćna tvar s poznatim učinkom Jedan ml suspenzije sadrži 0,03 mg benzalkonijeva klorida.
English: The same type of adverse reactions attributable to oral carbonic anhydrase inhibitors may occur with topical administration.
Croatian: Iste vrste nuspojava koje se pripisuju peroralno primijenjenim inhibitorima karboanhidraze moguće su i pri njihovoj topikalnoj primjeni.
English: Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses.
Croatian: Meke kontaktne leće mogu apsorbirati benzalkonijev klorid, zbog čega se može promijeniti njihova boja.
English: It is unknown whether topical SIMBRINZA is excreted in human milk.
Croatian: Nije poznato izlučuje li se topikalno primijenjena SIMBRINZA u majčino mlijeko.
English: 2, myalgia
Croatian: 2, mialgija
English: Uncommon: headache
Croatian: Manje često: glavobolja
English: If you use more SIMBRINZA than you should
Croatian: Ako primijenite više SIMBRINZE nego što ste trebali Isperite oko toplom vodom.
English: Caution is advised when using medicinal products such as antihypertensives and/or cardiac glycosides concomitantly with SIMBRINZA.
Croatian: Preporuča se oprez pri istodobnoj primjeni SIMBRINZE i lijekova kao što su antihipertenzivi i/ili srčani glikozidi.
English: SIMBRINZA is intended for local action within the eye. Assessment of human ocular exposure at efficacious doses is not feasible.
Croatian: Procjena izloženosti u ljudskom oku kod učinkovitih doza nije izvediva.
English: SIMBRINZA should not be used by women who are breast-feeding.
Croatian: SIMBRINZU ne smiju primjenjivati žene koje doje.
English: 1, corneal deposits (keratic precipitates)
Croatian: 2, blefaritis 1, depoziti na rožnici (precipitati na rožnici)
English: Least squares means derived from a statistical model that accounts for study site, 9 AM baseline IOP stratum, and correlated IOP measurements within patient
Croatian: Srednje vrijednosti dobivene metodom najmanjih kvadrata dobivene statističkim modelom koji uzima u obzir ispitivačku lokaciju, početnu vrijednost IOT -a u 9 sati ujutro i korelaciju dobivenih vrijednosti IOT-a u svakog bolesnika.
English: 2, medication residue Not known: chest pain
Croatian: 2, alopecija stezanje kože Nepoznato: edem lica
English: • General side effects: tremor, decreased sensation, loss of taste, abnormal liver function values as seen in a blood test, swelling of the face, joint pain, frequent urination, chest pain, swelling of the extremities.
Croatian: - Opće nuspojave: nevoljno drhtanje, smanjena osjetljivost, gubitak okusa, poremećeni nalazi pretraga jetrene funkcije, oticanje lica, bol u zglobovima, učestalo mokrenje, bol u prsnom košu,
English: 3, miosis Not known: visual disturbances
Croatian: 3, mioza Nepoznato: poremećaj vida 2, madaroza
English: There are no data on the effect of topical ocular administration of SIMBRINZA on human fertility.
Croatian: Nema podataka o utjecaju SIMBRINZE primijenjene topikalno u oko na plodnost u ljudi.
English: 2, flatulence hypoaesthesia oral
Croatian: 2, oralna hipoestezija
English: Hepatic impairment
Croatian: Propuštena doza
English: SIMBRINZA contains two active substances: brinzolamide and brimonidine tartrate.
Croatian: SIMBRINZA sadrži dvije djelatne tvari: brinzolamid i brimonidintartarat.
English: Boric acid
Croatian: Acidobazni poremećaji
English: methazolamide and dorzolamide - medicines that can affect the metabolism, such as chlorpromazine, methylphenidate and reserpine - antiviral, antiretroviral (used to treat Human Immunodeficiency Virus (HIV)) or antibiotic medicines - antiyeast or antifungal medicines - monoamine oxidase (MAO) inhibitors, or antidepressants including amitriptyline, nortriptyline,
Croatian: metazolamid i dorzolamid. - lijekove koji mogu utjecati na metabolizam, primjerice kloropromazin, metilfenidat i rezerpin - antivirotike, antiretrovirotike (koji se koriste u liječenju virusa humane imunodeficijencije
English: - If you have any further questions, ask your doctor, optometrist (optician) or pharmacist.
Croatian: - Ako imate dodatnih pitanja, obratite se liječniku, optometristu (optičaru) ili ljekarniku.
English: Brinzolamide is absorbed through the cornea following topical ocular administration.
Croatian: Brinzolamid se apsorbira kroz rožnicu nakon topikalne primjene u oko.
English: • Effects in the eye: eye surface damage with loss of cells, inflammation of the eyelid, deposits on the eye surface, sensitivity to light, swelling of the eye (affecting the cornea or eyelid), dry eye, eye discharge, watery eye, eyelid redness, abnormal or decreased sensation in eye, tired eye, reduced vision, double vision, product particles in eyes.
Croatian: Manje česte nuspojave (mogu se pojaviti u manje od 1 na 100 osoba) - Nuspojave na oku: oštećenje površine oka s gubitkom stanica, upala vjeđa, naslage na površini oka, osjetljivost na svjetlo, oticanje oka (učinak na rožnicu ili vjeđu), suho oko, iscjedak iz oka, pojačano suzenje, crvenilo vjeđa, poremećen ili smanjen osjet u oku, umorno oko, oslabljeni vid, dvoslike, čestice lijeka u očima.
English: If you wear soft contact lenses, do not use the drops with your lenses in. See section “Wearing contact lenses - SIMBRINZA contains benzalkonium chloride” below).
Croatian: Vidjeti dio “Nošenje kontaktnih leća - SIMBRINZA sadrži benzalkonijev klorid” ispod).
English: SIMBRINZA contains two active substances, brinzolamide and brimonidine tartrate.
Croatian: SIMBRINZA sadrži dvije djelatne tvari, brinzolamid i brimonidintartarat.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE NALJEPNICA NA BOCI
English: Brinzolamide is a carbonic anhydrase inhibitor and, although administered topically, is absorbed systemically.
Croatian: Brinzolamid je inhibitor karboanhidraze i, premda se primjenjuje topikalno, apsorbira se sistemski.
English: 2, scleral pigmentation
Croatian: 2, pigmentacija bjeloočnice
English: 2, feeling abnormal
Croatian: 2, abnormalan osjećaj osjećaj treme
English: If you have any further questions on the use of this medicine, ask your doctor, optometrist (optician) or pharmacist.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se liječniku, optometristu (optičaru) ili ljekarniku.
English: 2, amnesia
Croatian: 2, amnezija gubitak pamćenja
English: 2, madarosis
Croatian: 2, mučnina
English: 2, bronchial hyperactivity 2, pharyngolaryngeal pain
Croatian: 2, bronhalna hiperaktivnost faringolaringealna bol2, suho grlo1, kašalj2, epistaksa2, kongestija gornjeg dijela dišnog sustava
English: 2, subconjunctival cyst
Croatian: 2, subkonjunktivna cista
English: In a study of brinzolamide in subjects with renal impairment, a 1.6- to 2.8-fold increase in the systemic exposure to brinzolamide and N-desethylbrinzolamide between normal and moderately renally-impaired subjects was demonstrated.
Croatian: Ispitivanje brinzolamida u ispitanika s oštećenom bubrežnom funkcijom pokazalo je da je sistemska izloženost brinzolamidu i Ndesetilbrinzolamidu u ispitanika s umjereno oštećenom bubrežnom funkcijom bila 1,6 - 2,8 puta veća nego u onih s urednom bubrežnom funkcijom.
English: Careful monitoring of patients with compromised corneas, such as patients with diabetes mellitus or corneal dystrophies, is recommended.
Croatian: Kod bolesnika s oštećenjem rožnice, npr. kod bolesnika s dijabetes melitusom ili distrofijom rožnice, preporučuje se pažljivo praćenje.
English: 1, asthenopia
Croatian: 1, pterigij
English: Uncommon: pain
Croatian: Manje često: bol
English: -8.1 (n=346) -8.2 (n=330)
Croatian: -8,1 (n=346)
English: SIMBRINZA contains brinzolamide, a sulphonamide inhibitor of carbonic anhydrase and, although administered topically, is absorbed systemically.
Croatian: SIMBRINZA sadrži brinzolamid, sulfonamidni inhibitor karboanhidraze i, premda se primjenjuje topikalno, apsorbira se sistemski.
English: a
Croatian: CI)
English: 2, throat irritation
Croatian: 2, razdražljivost
English: 5.3 Preclinical safety data
Croatian: 5.3 Neklinički podaci o sigurnosti primjene Brinzolamid
English: 2, memory impairment
Croatian: 2, oticanje oka
English: 1, sneezing Not known: asthma Gastrointestinal disorders Common: dry mouth Uncommon: dyspepsia
Croatian: Poremećaji probavnog sustava Često: suha usta Manje često: dispepsija
English: Mean percent IOP reductions from baseline with SIMBRINZA ranged from 25 to 37%.The percentages of patients with an IOP measurement less than 18 mmHg were similar across study visits for the same time point through Month 6 in the SIMBRINZA and Brinzolamide + Brimonidine groups.
Croatian: Postotak bolesnika s IOT-om nižim od 18 mmHg bio je, pri primjeni SIMBRINZE i brinzolamida + brimonidina sličan pri svakom posjetu u istoj vremenskoj točki do 6. mjeseca ispitivanja.
English: -8.4 (n=394) -8.4 (n=384)
Croatian: -8,4 (n=394)
English: Infections and infestations
Croatian: Klasifikacija organskih sustava Nuspojave Infekcije i infestacije
English: 1, meibomianitis
Croatian: 1, omaglica
English: 2, diplopia glare
Croatian: 2, diplopija
English: 2, rash maculopapular pruritus generalised
Croatian: 2, osip makulopapularni osip
English: SIMBRINZA contains brinzolamide, an inhibitor of carbonic anhydrase, and although administered topically, is absorbed systemically.
Croatian: SIMBRINZA sadrži brinzolamid, inhibitor karboanhidraze i premda se primjenjuje topikalno, apsorbira se sistemski.
English: -8.5 (n=384) -8.3 (n=373)
Croatian: -8,3 (n=373)
English: 2, lacrimation increased
Croatian: 2, pojačano suzenje
English: 1, oesophagitis
Croatian: 1, astenopija
English: 2, eye swelling 2, eyelid oedema
Croatian: 2, edem vjeđe konjunktivalni edem 1, suho oko
English: -8.5 (n=384) -8.4 (n=377)
Croatian: -8,4 (n=377)
English: 1, rhinorrhoea
Croatian: 1, rinoreja nadražaj grla
English: Signs included sleepiness, floppiness, low body temperature, paleness and breathing difficulties.
Croatian: U djece koja su zabunom progutala lijek koji je sadržavao brimonidin, prijavljene su ozbiljne nuspojave, čiji znakovi uključuju pospanost, mlohavost, nisku tjelesnu temperaturu, bljedilo i poteškoće disanja.
English: Common: eye allergy 1, keratitis
Croatian: Često: alergija oka
English: 2, skin tightness
Croatian: 2, nelagoda u prsištu
English: 2, vomiting 2, nausea
Croatian: 2, nelagoda u abdomenu proljev 2, povraćanje
English: Uncommon: renal pain Not known: pollakiuria
Croatian: Nepoznato: polakizurija
English: Figure 1 Mean a diurnal (9 AM, +2 hrs, +7 hrs) IOP change from baseline (mmHg)Contribution of elements study aLeast squares means derived from a statistical model that accounts for study site, 9 AM baseline IOP stratum, and correlated IOP measurements within patient.
Croatian: Slika 1 Srednja a dnevna (9 sati ujutro, +2 h, +7 h) promjena IOT-a u odnosu na početni (mmHg) - Ispitivanje doprinosa pojedinih elemenata
English: 2, bradycardia
Croatian: 1, urtikarija
English: • Effects in the eye: allergic conjunctivitis (eye allergy), eye surface inflammation, eye pain, eye discomfort, blurred or abnormal vision, eye redness
Croatian: nelagoda u oku, zamagljen ili poremećen vid, crvenilo oka - Opće nuspojave: omamljenost, omaglica, promjena osjeta okusa, suha usta
English: 2, paraesthesia oral
Croatian: 2, oralna parestezija
English: 1, conjunctival disorder (papillae)
Croatian: 1, poremećaj konjunktive
English: 2, frequent bowel movements
Croatian: 2, često pražnjenje crijeva flatulencija
English: 2, abdominal discomfort diarrhoea
Croatian: 2, nazalna kongestija
English: 2, arrhythmia palpitations
Croatian: 3, palpitacije
English: - If you get any side effects, talk to your doctor, optometrist (optician) or pharmacist.
Croatian: - Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika, optometristu (optičara) ili ljekarnika.
English: If you get any side effects, talk to your doctor, optometrist (optician) or pharmacist.
Croatian: Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika, optometristu (optičara) ili ljekarnika.
English: Propylene glycol
Croatian: Meibomovih žlijezda
English: 1, dry eye
Croatian: 1, bol u oku
English: SIMBRINZA Mean a
Croatian: Srednja vrijednost a
English: Below is a brief description of the studies and their results:
Croatian: U nastavku je opis ispitivanja i njihovih rezultata:
English: Further information on Humira can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/humira.
Croatian: Više informacija o lijeku Humira nalazi se na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/humira.
English: Some rare but serious side effects have been reported, including serious infections.
Croatian: Zabilježene su neke rijetke, ozbiljne nuspojave, uključujući teške infekcije.
English: However, these are considered to be manageable and specific recommendations are given to help doctors manage these risks.
Croatian: Međutim, smatra se da se one mogu kontrolirati te su utvrđene posebne preporuke kako bi se liječnicima pomoglo u kontroli tih rizika.
English: Humira is given as an injection under the skin, usually every 2 weeks.
Croatian: Humira se primjenjuje potkožnom injekcijom, obično svaka dva tjedna.
English: What is Humira and what is it used for?
Croatian: Što je Humira i za što se primjenjuje?
English: What measures are being taken to ensure the safe and effective use of Humira?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Humira?
English: Other information about Humira
Croatian: Ostale informacije o lijeku Humira
English: Humira received a marketing authorisation valid throughout the EU on 8 September 2003.
Croatian: Lijek Humira dobio je odobrenje za stavljanje u promet koje je na snazi u EU-u od 8. rujna 2003.
English: The study in younger children (aged 2 to 4 years) showed that the majority of children responded well to Humira treatment and this response was maintained after 24 weeks.
Croatian: Ispitivanje na mlađoj djeci (u dobi od 2 do 4 godine) pokazalo je da je većina djece dobro reagirala na lijek Humira i taj je odgovor održan nakon 24 tjedna.
English: The dose and frequency of injection depends on the condition to be treated and the dose for a child is calculated according to the child's weight.
Croatian: Doza i učestalost injekcije ovisi o stanju koje je potrebno liječiti, a doza za djecu izračunava se u skladu s težinom djeteta.
English: The proportions of patients taking placebo who achieved this goal were 28% in the first study and 26% in the second.
Croatian: Postotak bolesnika koji su uzimali placebo, kod kojih je ostvaren taj cilj, iznosio je 28 % u prvom ispitivanju i 26 % u drugom ispitivanju.
English: What are the risks associated with Humira?
Croatian: Koji su rizici povezani s lijekom Humira?
English: The first study involved adults whose disease was not controlled with high doses of corticosteroids.
Croatian: Prvo ispitivanje obuhvatilo je odrasle osobe čija se bolest nije mogla kontrolirati visokim dozama kortikosteroida.
English: Why is Humira authorised in the EU?
Croatian: Zašto je lijek Humira odobren u EU-u?
English: Humira is a medicine that acts on the immune system and is used to treat the following conditions:
Croatian: Humira je lijek koji djeluje na imunosni sustav te se koristi za liječenje sljedećih stanja:
English: Patients or their carers can inject Humira once they have been trained.
Croatian: Bolesnici ili njihovi njegovatelji mogu injicirati lijek Humira nakon odgovarajuće obuke.
English: Humira and other medicines of its class may also affect the ability of the immune system to fight off infections and cancer, and there have been some cases of serious infections and blood cancers in patients using Humira.
Croatian: Humira i drugi lijekovi u tom razredu mogu utjecati na sposobnost imunosnog sustava da se bori protiv infekcija i raka, pa su zabilježeni slučajevi ozbiljnih infekcija i raka krvi u bolesnika koji su primali lijek Humira.
English: An overview of Humira and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Humira i zašto je odobren u EU-u
English: In patients who had not taken methotrexate in the past, the combination of Humira and methotrexate was also more effective than methotrexate alone.
Croatian: Kod bolesnika koji nisu prethodno uzimali metotreksat, kombinacija lijekova Humira i metotreksata bila je također djelotvornija od samog metotreksata.
English: Humira must not be used in patients with active tuberculosis or other severe infections, or in patients with moderate to severe heart failure (an inability of the heart to pump enough blood around the body).
Croatian: Humira se ne smije primjenjivati u bolesnika s aktivnom tuberkulozom ili drugim teškim infekcijama ni u bolesnika s umjerenim do teškim zatajenjem srca (nesposobnost srca da pumpa dovoljne količine krvi u tijelu).
English: Humira, when used as directed, has been shown in clinical trials to be effective at reducing important symptoms of each of the conditions for which it is approved.
Croatian: Lijek Humira, kada se koristio prema naputku, u kliničkim se ispitivanjima pokazao učinkovitim u smanjenju važnih simptoma svakog stanja za čije je liječenje odobren.
English: Side effects reported with Humira are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Humira pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: Patients treated with Humira must be given a reminder card with information on the safety of the medicine.
Croatian: Bolesnici koji se liječe lijekom Humira moraju dobiti karticu s podsjetnikom na informacije o sigurnosti lijeka.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Humira have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati radi sigurne i učinkovite primjene lijeka Humira nalaze se u sažetku opisa svojstava i u uputi o lijeku.
English: More than twenty main studies involving over 9,500 patients have looked at the effects of Humira in reducing symptoms of inflammatory conditions.
Croatian: U više od dvadeset glavnih ispitivanja koja su obuhvatila više od 9 500 bolesnika ispitivan je učinak lijeka Humira na smanjenje simptoma upalnih stanja.
English: The active substance in Humira, adalimumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a substance in the body called tumour necrosis factor (TNF).
Croatian: Djelatna tvar u lijeku Humira, adalimumab, monoklonsko je protutijelo (vrsta proteina) namijenjeno prepoznavanju i vezivanju za tvar u tijelu zvanu faktor tumorske nekroze (TNF).
English: As for all medicines, data on the use of Humira are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Humira kontinuirano se prate.
English: Patients adding Humira also had less joint damage and less reduction in physical function after a year.
Croatian: Bolesnici koji su dodavali lijek Humira u terapiju imali su također manja oštećenja zglobova i manja ograničenja fizičke funkcije nakon godine dana.
English: Humira is mostly used in adults when their conditions are severe, moderately severe or getting worse, or when patients cannot use other treatments.
Croatian: Humira se prvenstveno koristi u odraslih osoba kod ozbiljnog, umjereno ozbiljnog stanja bolesti ili onog koje se pogoršava, odnosno kad bolesnici ne mogu primiti drugu terapiju.
English: • In non-infectious uveitis, Humira was found effective in 3 studies.
Croatian: • Kada je riječ o neinfektivnom uveitisu, lijek Humira pokazao se djelotvornim u trima ispitivanjima.
English: Treatment with Humira must be started and supervised by a doctor who has experience in the treatment of the diseases that Humira is used for.
Croatian: Liječenje lijekom Humira mora započeti i nadzirati liječnik s iskustvom u liječenju bolesti za koje se Humira koristi.
English: The European Medicines Agency decided that Humira's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi od lijeka Humira nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u Europskoj uniji.
English: The second study involved adults whose uveitis was under control with a corticosteroid but the corticosteroid dose was then reduced or stopped and Humira or placebo introduced.
Croatian: Drugo je ispitivanje obuhvatilo odrasle osobe kod kojih je postignuta kontrola uveitisa kortikosteroidima, ali kod kojih je davanje kortikosteroida zatim smanjeno ili prekinuto, a počelo se s primjenom lijeka Humira ili placeba.
English: What benefits of Humira have been shown in studies?
Croatian: Koje su koristi od lijeka Humira utvrđene u ispitivanjima?
English: The most common side effects with Humira (which may affect more than 1 in 10 people) are infections (including in the nose, throat and sinuses), injection site reactions (redness, itching, bleeding, pain or swelling), headache and muscle and bone pain.
Croatian: Najčešće nuspojave povezane s lijekom Humira (koje se mogu javiti u više od 1 na 10 osoba) jesu infekcije (uključujući infekcije nosa, ždrijela i sinusa), reakcije na mjestu injiciranja (crvenilo, svrbež, krvarenje, bol ili oticanje), glavobolja i bol u mišićno-koštanom sustavu.
English: For detailed information on the use of Humira in all conditions, including when it can be used in children, see package leaflet or contact your doctor or pharmacist.
Croatian: Detaljne informacije o primjeni lijeka Humira za sva stanja, kao i kada se može primjenjivati u djece, pročitajte u uputi o lijeku odnosno obratite se liječniku ili ljekarniku.